Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.09.2021 | Case report

Ramipril

Increase in severity and frequency of angioedema: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Jesenak M, et al. Successful use of recombinant human c1-inh in a patient with acquired angioedema due to c1 inhibitor deficiency and an unusually high titer of anti-c1-inhibitor autoantibodies. Journal of Investigational Allergology and Clinical Immunology 31: 255-256, No. 3, 2021. Available from: URL: http://www.jiaci.org/revistas/vol31issue3_6-2.pdf Jesenak M, et al. Successful use of recombinant human c1-inh in a patient with acquired angioedema due to c1 inhibitor deficiency and an unusually high titer of anti-c1-inhibitor autoantibodies. Journal of Investigational Allergology and Clinical Immunology 31: 255-256, No. 3, 2021. Available from: URL: http://​www.​jiaci.​org/​revistas/​vol31issue3_​6-2.​pdf
Metadaten
Titel
Ramipril
Increase in severity and frequency of angioedema: case report
Publikationsdatum
01.09.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-02361-4

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Infliximab

Case report

Prucalopride